Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients.

Nicosia L, Mazzola R, Rigo M, Figlia V, Giaj-Levra N, Napoli G, Ricchetti F, Corradini S, Ruggieri R, Alongi F.

J Cancer Res Clin Oncol. 2019 Oct;145(10):2547-2554. doi: 10.1007/s00432-019-02983-3. Epub 2019 Jul 19.

PMID:
31324979
2.

Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.

Stavreva N, Stavrev P, Balabanova A, Nahum A, Ruggieri R, Pressyanov D.

Phys Med. 2019 Jul;63:79-86. doi: 10.1016/j.ejmp.2019.05.007. Epub 2019 May 31.

PMID:
31221413
3.

Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia.

Cafaro A, Cecere A, Ruggieri R, Iorio E, Giardinelli F, Ciccone MM, Casamassima V, Grimaldi M, Langialonga T, Pepe M.

Cardiol J. 2019;26(2):196-197. doi: 10.5603/CJ.2019.0041. No abstract available.

4.

Linac-based radiosurgery for multiple brain metastases: Comparison between two mono-isocenter techniques with multiple non-coplanar arcs.

Ruggieri R, Naccarato S, Mazzola R, Ricchetti F, Corradini S, Fiorentino A, Alongi F.

Radiother Oncol. 2019 Mar;132:70-78. doi: 10.1016/j.radonc.2018.11.014. Epub 2018 Dec 21.

PMID:
30825972
5.

Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach : A prospective observational study.

Mazzola R, Ruggieri R, Figlia V, Rigo M, Giaj Levra N, Ricchetti F, Nicosia L, Corradini S, Alongi F.

Strahlenther Onkol. 2019 Aug;195(8):719-724. doi: 10.1007/s00066-018-01419-0. Epub 2019 Jan 28.

PMID:
30689026
6.

Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.

Fiorentino A, Gregucci F, Mazzola R, Figlia V, Ricchetti F, Sicignano G, Giajlevra N, Ruggieri R, Fersino S, Naccarato S, Massocco A, Corradini S, Alongi F.

Radiol Med. 2019 Apr;124(4):309-314. doi: 10.1007/s11547-018-0976-2. Epub 2018 Dec 13.

PMID:
30547358
7.

Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients : A mono-institutional experience on 110 brain metastases.

Gregucci F, Fiorentino A, Corradini S, Figlia V, Mazzola R, Ricchetti F, Ruggieri R, Alongi F.

Strahlenther Onkol. 2019 Mar;195(3):218-225. doi: 10.1007/s00066-018-1405-0. Epub 2018 Nov 26.

PMID:
30478669
8.

First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases.

Alongi F, Fiorentino A, Gregucci F, Corradini S, Giaj-Levra N, Romano L, Rigo M, Ricchetti F, Beltramello A, Lunardi G, Mazzola R, Ruggieri R.

J Cancer Res Clin Oncol. 2019 Jan;145(1):193-200. doi: 10.1007/s00432-018-2781-7. Epub 2018 Oct 31.

PMID:
30382369
9.

PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.

Ding Z, Dhruv H, Kwiatkowska-Piwowarczyk A, Ruggieri R, Kloss J, Symons M, Pirrotte P, Eschbacher JM, Tran NL, Loftus JC.

Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.

10.

Investigation of the effect of natural tumor cell death on radiotherapy outcomes.

Stavrev P, Stavreva N, Penev D, Nahum A, Ruggieri R, Pressyanov D.

Phys Med Biol. 2018 Oct 9;63(20):205001. doi: 10.1088/1361-6560/aae05d.

PMID:
30204124
11.

Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery.

Alongi F, Fiorentino A, Ruggieri R, Ricchetti F, Kupelian P.

Clin Exp Metastasis. 2018 Oct;35(7):601-603. doi: 10.1007/s10585-018-9933-7. Epub 2018 Aug 24.

PMID:
30143886
12.

Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.

Mazzola R, Fersino S, Ferrera G, Targher G, Figlia V, Triggiani L, Pasinetti N, Lo Casto A, Ruggieri R, Magrini SM, Alongi F.

Med Oncol. 2018 Aug 4;35(9):121. doi: 10.1007/s12032-018-1190-8.

PMID:
30076479
13.

Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer.

Alongi F, Mazzola R, Fiorentino A, Corradini S, Aiello D, Figlia V, Gregucci F, Ballario R, Cavalleri S, Ruggieri R.

Strahlenther Onkol. 2019 Feb;195(2):113-120. doi: 10.1007/s00066-018-1338-7. Epub 2018 Jul 12.

PMID:
30003292
14.

Stereotactic body radiation therapy for liver oligometastases: predictive factors of local response by 18F-FDG-PET/CT.

Mazzola R, Fersino S, Alongi P, Di Paola G, Gregucci F, Aiello D, Tebano U, Pasetto S, Ruggieri R, Salgarello M, Alongi F.

Br J Radiol. 2018 Jul;91(1088):20180058. doi: 10.1259/bjr.20180058. Epub 2018 May 23.

15.

Increased Efficacy of Stereotactic Ablative Radiation Therapy after Bevacizumab in Lung Oligometastases from Colon Cancer.

Mazzola R, Tebano U, Aiello D, Di Paola G, Giaj-Levra N, Ricchetti F, Fersino S, Fiorentino A, Ruggieri R, Alongi F.

Tumori. 2017 Dec 1:tj5000701. doi: 10.5301/tj.5000701. [Epub ahead of print]

PMID:
29737958
16.

Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.

Mazzola R, Fersino S, Aiello D, Gregucci F, Tebano U, Corradini S, Di Paola G, Cirillo M, Tondulli L, Ruffo G, Ruggieri R, Alongi F.

Strahlenther Onkol. 2018 Sep;194(9):835-842. doi: 10.1007/s00066-018-1306-2. Epub 2018 Apr 25.

PMID:
29696321
17.

Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.

Ruggieri R, Naccarato S, Mazzola R, Ricchetti F, Corradini S, Fiorentino A, Alongi F.

Radiat Oncol. 2018 Mar 5;13(1):38. doi: 10.1186/s13014-018-0985-2.

18.

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism.

Markowitz D, Ha G, Ruggieri R, Symons M.

Onco Targets Ther. 2017 Nov 24;10:5633-5642. doi: 10.2147/OTT.S143096. eCollection 2017.

19.

Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study.

Fiorentino A, Tebano U, Sicignano G, Ricchetti F, Di Paola G, Aiello D, Giaj-Levra N, Mazzola R, Fersino S, Ruggieri R, Alongi F.

Phys Med. 2018 May;49:135-138. doi: 10.1016/j.ejmp.2017.09.129. Epub 2017 Sep 23.

PMID:
28951047
20.

Colony Stimulating Factor-1 Receptor Inhibitors-A 4 for 1 Deal in the Desire to Improve Glioma Radiotherapy.

Skeie B, Ruggieri R, Boockvar JA, Symons M.

Neurosurgery. 2017 Sep 1;81(3):N27-N28. doi: 10.1093/neuros/nyx389. No abstract available.

PMID:
28859456
21.

Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance.

Ammendola M, Sacco R, Vescio G, Zuccalà V, Luposella M, Patruno R, Zizzo N, Gadaleta C, Marech I, Ruggieri R, Kocak IF, Ozgurtas T, Gadaleta CD, Sammarco G, Ranieri G.

Therap Adv Gastroenterol. 2017 Apr;10(4):353-360. doi: 10.1177/1756283X16673981. Epub 2017 Feb 1.

22.

Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.

Fiorentino A, Giaj-Levra N, Tebano U, Mazzola R, Ricchetti F, Fersino S, Di Paola G, Aiello D, Ruggieri R, Alongi F.

Radiol Med. 2017 Sep;122(9):676-682. doi: 10.1007/s11547-017-0768-0. Epub 2017 Apr 26.

PMID:
28447313
23.

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.

De Witt M, Gamble A, Hanson D, Markowitz D, Powell C, Al Dimassi S, Atlas M, Boockvar J, Ruggieri R, Symons M.

Mol Med. 2017 Apr;23:50-56. doi: 10.2119/molmed.2017.00011. Epub 2017 Apr 5.

24.

Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.

Fersino S, Tebano U, Mazzola R, Giaj-Levra N, Ricchetti F, Di Paola G, Fiorentino A, Sicignano G, Naccarato S, Ruggieri R, Cavalleri S, Alongi F.

Clin Genitourin Cancer. 2017 Aug;15(4):e667-e673. doi: 10.1016/j.clgc.2017.01.025. Epub 2017 Feb 6.

PMID:
28237181
25.

Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.

Fiorentino A, Mazzola R, Naccarato S, Giaj-Levra N, Fersino S, Sicignano G, Tebano U, Ricchetti F, Ruggieri R, Alongi F.

Radiol Med. 2017 Jun;122(6):464-471. doi: 10.1007/s11547-017-0741-y. Epub 2017 Feb 21.

PMID:
28224401
26.

Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.

Ruggieri R, Stavrev P, Naccarato S, Stavreva N, Alongi F, Nahum AE.

Phys Med. 2017 Dec;44:188-195. doi: 10.1016/j.ejmp.2016.12.012. Epub 2017 Jan 24.

PMID:
28130055
27.

Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT.

Mazzola R, Fiorentino A, Di Paola G, Giaj Levra N, Ricchetti F, Fersino S, Tebano U, Pasetto S, Ruggieri R, Salgarello M, Alongi F.

J Thorac Oncol. 2017 Mar;12(3):547-555. doi: 10.1016/j.jtho.2016.11.2234. Epub 2017 Jan 24.

28.

Simultaneous integrated bilateral breast and nodal irradiation with volumetric arc therapy: case report and literature review.

Fiorentino A, Tebano U, Ruggieri R, Ricchetti F, Alongi F.

Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000568. Review.

PMID:
27716877
29.

Technical Note: Multicenter study of TrueBeam FFF beams with a new stereotactic diode: Can a common small field signal ratio curve be defined?

Cagni E, Russo S, Reggiori G, Bresciani S, Fedele D, Iori M, Marino C, Nardiello B, Ruggieri R, Strigari L, Mancosu P.

Med Phys. 2016 Oct;43(10):5570.

PMID:
27782701
30.

Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal?

Fiorentino A, Ruggieri R, Giaj-Levra N, Sicignano G, Di Paola G, Naccarato S, Fersino S, Mazzola R, Tebano U, Ricchetti F, Alongi F.

Radiol Med. 2017 Feb;122(2):146-153. doi: 10.1007/s11547-016-0700-z. Epub 2016 Oct 24.

PMID:
27778239
31.

Stereotactic body radiation therapy with hydrogel spacer: a salvage reirradiation strategy for prostate cancer recurrence.

Fiorentino A, Giaj Levra N, Mazzola R, Fersino S, Ricchetti F, Ballario R, Ruggieri R, Alongi F.

Minerva Urol Nefrol. 2016 Oct;68(5):464-6. No abstract available.

PMID:
27643656
32.

Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.

Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J, Symons M, Ruggieri R, Raja K, Banerjee P.

Int J Cancer. 2016 Dec 15;139(12):2838-2849. doi: 10.1002/ijc.30398. Epub 2016 Sep 24.

33.

Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams.

Ruggieri R, Naccarato S, Stavrev P, Stavreva N, Pasetto S, Salamone I, Alongi F.

Med Phys. 2016 Aug;43(8):4729. doi: 10.1118/1.4958960.

PMID:
27487890
34.

Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.

Mazzola R, Ricchetti F, Fiorentino A, Levra NG, Fersino S, Di Paola G, Ruggieri R, Alongi F.

Technol Cancer Res Treat. 2017 Jun;16(3):310-315. doi: 10.1177/1533034616655055. Epub 2016 Jul 8.

35.

Low-dose bath with volumetric modulated arc therapy in breast cancer: "Much ado about nothing?".

Alongi F, Giaj-Levra N, Fiorentino A, Mazzola R, Fersino S, Ricchetti F, Ruggieri R.

Tumori. 2016 Aug 3;102(4):335-6. doi: 10.5301/tj.5000516. Epub 2016 Jun 17. No abstract available.

PMID:
27339088
36.

Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.

Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G.

Clin Transl Oncol. 2017 Feb;19(2):189-196. doi: 10.1007/s12094-016-1522-0. Epub 2016 Jun 7.

PMID:
27271749
37.

Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response.

Mazzola R, Fiorentino A, Ricchetti F, Giaj Levra N, Fersino S, Di Paola G, Lo Casto A, Ruggieri R, Alongi F.

Br J Radiol. 2016 Aug;89(1064):20160146. doi: 10.1259/bjr.20160146. Epub 2016 Jun 1.

38.

Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.

Markowitz D, Powell C, Tran NL, Berens ME, Ryken TC, Vanan M, Rosen L, He M, Sun S, Symons M, Al-Abed Y, Ruggieri R.

Mol Cancer Ther. 2016 Aug;15(8):1799-808. doi: 10.1158/1535-7163.MCT-15-0849. Epub 2016 May 20.

39.

Applying radiobiological plan ranking methodology to VMAT prostate SBRT.

Stavrev P, Ruggieri R, Stavreva N, Naccarato S, Alongi F.

Phys Med. 2016 Apr;32(4):636-41. doi: 10.1016/j.ejmp.2016.03.019. Epub 2016 Apr 13.

PMID:
27085287
40.

Cachexia induces head and neck changes in locally advanced oropharyngeal carcinoma during definitive cisplatin and image-guided volumetric-modulated arc radiation therapy.

Mazzola R, Ricchetti F, Fiorentino A, Di Paola G, Fersino S, Giaj Levra N, Ruggieri R, Alongi F.

Eur J Clin Nutr. 2016 Jun;70(6):738-42. doi: 10.1038/ejcn.2016.61. Epub 2016 Apr 13.

PMID:
27071508
41.

Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.

Giglioli FR, Strigari L, Ragona R, Borzì GR, Cagni E, Carbonini C, Clemente S, Consorti R, El Gawhary R, Esposito M, Falco MD, Fedele D, Fiandra C, Frassanito MC, Landoni V, Loi G, Lorenzini E, Malisan MR, Marino C, Menghi E, Nardiello B, Nigro R, Oliviero C, Pastore G, Quattrocchi M, Ruggieri R, Redaelli I, Reggiori G, Russo S, Villaggi E, Casati M, Mancosu P.

Phys Med. 2016 Apr;32(4):600-6. doi: 10.1016/j.ejmp.2016.03.015. Epub 2016 Apr 6.

PMID:
27061871
42.

SBRT for prostate cancer: Challenges and features from a physicist prospective.

Mancosu P, Clemente S, Landoni V, Ruggieri R, Alongi F, Scorsetti M, Stasi M.

Phys Med. 2016 Mar;32(3):479-84. doi: 10.1016/j.ejmp.2016.03.011. Epub 2016 Apr 6. Review.

PMID:
27061869
43.

Radioresistance of Brain Tumors.

Kelley K, Knisely J, Symons M, Ruggieri R.

Cancers (Basel). 2016 Mar 30;8(4). pii: E42. doi: 10.3390/cancers8040042. Review.

44.

Neuro-oncology biotech industry progress report.

Chakraborty S, Bodhinayake I, Chiluwal A, Langer DJ, Ruggieri R, Symons M, Boockvar JA.

J Neurooncol. 2016 May;128(1):175-182. doi: 10.1007/s11060-016-2087-z. Epub 2016 Feb 20. Review.

PMID:
26897014
45.

The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.

Rey C, Faustin B, Mahouche I, Ruggieri R, Brulard C, Ichas F, Soubeyran I, Lartigue L, De Giorgi F.

Oncogene. 2016 Jun 16;35(24):3190-200. doi: 10.1038/onc.2015.379. Epub 2015 Nov 2.

PMID:
26522728
46.

The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy.

Mazzola R, Fersino S, Fiorentino A, Ricchetti F, Giaj Levra N, Di Paola G, Sicignano G, Naccarato S, Ruggieri R, Alongi F.

Clin Transl Oncol. 2016 Mar;18(3):317-21. doi: 10.1007/s12094-015-1371-2. Epub 2015 Aug 7.

PMID:
26250766
47.

Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.

Ruggieri R, Naccarato S, Stavrev P, Stavreva N, Fersino S, Giaj Levra N, Mazzola R, Mancosu P, Scorsetti M, Alongi F.

Br J Radiol. 2015 Oct;88(1054):20140736. doi: 10.1259/bjr.20140736. Epub 2015 Aug 3.

48.

Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study.

Giaj Levra N, Sicignano G, Fiorentino A, Fersino S, Ricchetti F, Mazzola R, Naccarato S, Ruggieri R, Alongi F.

Radiol Med. 2016 Jan;121(1):60-9. doi: 10.1007/s11547-015-0563-8. Epub 2015 Aug 1.

PMID:
26231251
49.

On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.

Stavrev P, Stavreva N, Ruggieri R, Nahum A.

Phys Med Biol. 2015 Aug 7;60(15):N293-9. doi: 10.1088/0031-9155/60/15/N293. Epub 2015 Jul 28.

PMID:
26215150
50.

Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.

Fiorentino A, Mazzola R, Ricchetti F, Giaj Levra N, Fersino S, Naccarato S, Sicignano G, Ruggieri R, Di Paola G, Massocco A, Gori S, Alongi F.

Cancer Radiother. 2015 Aug;19(5):289-94. doi: 10.1016/j.canrad.2015.02.013. Epub 2015 Jul 20.

PMID:
26206732

Supplemental Content

Loading ...
Support Center